- Home
- CLS vs DXCM Comparison
CLS vs DXCM Comparison
Compare CLS & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLS
- DXCM
- Stock Information
- Founded
- CLS 1994
- DXCM 1999
- Country
- CLS Canada
- DXCM United States
- Employees
- CLS N/A
- DXCM N/A
- Industry
- CLS Electrical Products
- DXCM Medical/Dental Instruments
- Sector
- CLS Technology
- DXCM Health Care
- Exchange
- CLS Nasdaq
- DXCM Nasdaq
- Market Cap
- CLS 31.1B
- DXCM 31.7B
- IPO Year
- CLS 1998
- DXCM 2005
- Fundamental
- Price
- CLS $344.48
- DXCM $58.22
- Analyst Decision
- CLS Buy
- DXCM Strong Buy
- Analyst Count
- CLS 13
- DXCM 20
- Target Price
- CLS $296.08
- DXCM $92.05
- AVG Volume (30 Days)
- CLS 3.2M
- DXCM 5.6M
- Earning Date
- CLS 10-27-2025
- DXCM 10-30-2025
- Dividend Yield
- CLS N/A
- DXCM N/A
- EPS Growth
- CLS 103.66
- DXCM 7.75
- EPS
- CLS 6.15
- DXCM 1.80
- Revenue
- CLS $11,281,700,000.00
- DXCM $4,515,900,000.00
- Revenue This Year
- CLS $20.66
- DXCM $17.01
- Revenue Next Year
- CLS $19.38
- DXCM $15.36
- P/E Ratio
- CLS $55.31
- DXCM $32.40
- Revenue Growth
- CLS 22.09
- DXCM 14.21
- 52 Week Low
- CLS $58.05
- DXCM $56.45
- 52 Week High
- CLS $360.99
- DXCM $93.25
- Technical
- Relative Strength Index (RSI)
- CLS 77.98
- DXCM 24.58
- Support Level
- CLS $329.24
- DXCM $66.42
- Resistance Level
- CLS $355.50
- DXCM $69.17
- Average True Range (ATR)
- CLS 18.79
- DXCM 2.08
- MACD
- CLS 7.05
- DXCM -0.29
- Stochastic Oscillator
- CLS 86.55
- DXCM 11.36
About CLS Celestica Inc.
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.